Why Teligent Rose ~10.4% Yesterday
On June 14, Teligent (TLGT) stock rose ~10.4% on the news of the FDA approval of its diflorasone diacetate ointment 0.05%. Investors were pleased with the news, and TLGT stock soared more than 10%. Teligent plans to launch the product in the third quarter of 2018.